US FDA's Mini-Sentinel pilot speeds up analysis of medical product safety questions
This article was originally published in Clinica
Executive Summary
The pilot phase of the US FDA's Sentinel System for monitoring in real-time the safety of drugs and medical devices is enabling scientist to evaluate safety questions far more quickly than using traditional channel, the agency has revealed.